SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-05-067234
Filing Date
2005-12-16
Accepted
2005-12-16 11:57:20
Documents
1
Period of Report
2005-12-14

Document Format Files

Seq Description Document Type Size
1 12/14/2005 ACQUISITION rrd99988.html 3  
1 12/14/2005 ACQUISITION rrd99988.xml 3 3582
  Complete submission text file 0001181431-05-067234.txt   5414
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 190 SOUTH LASALLE ST SUITE 2800 CHICAGO IL 60603 312-444-6040
ESSEX WOODLANDS HEALTH VENTURES FUND VI L P (Reporting) CIK: 0001276801 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24274 | Film No.: 051268797